nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.117	0.201	CbGbCtD
Anastrozole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0978	0.169	CbGbCtD
Anastrozole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0933	0.161	CbGbCtD
Anastrozole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0612	0.105	CbGbCtD
Anastrozole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0569	0.0981	CbGbCtD
Anastrozole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0457	0.0788	CbGbCtD
Anastrozole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0419	0.0722	CbGbCtD
Anastrozole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0261	0.045	CbGbCtD
Anastrozole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0239	0.0413	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0163	0.0281	CbGbCtD
Anastrozole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000301	0.000715	CcSEcCtD
Anastrozole—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.0003	0.000715	CcSEcCtD
Anastrozole—Cough—Etoposide—peripheral nervous system neoplasm	0.000299	0.000712	CcSEcCtD
Anastrozole—Headache—Topotecan—peripheral nervous system neoplasm	0.000299	0.000711	CcSEcCtD
Anastrozole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.00071	CcSEcCtD
Anastrozole—Rash—Tretinoin—peripheral nervous system neoplasm	0.000298	0.00071	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000298	0.00071	CcSEcCtD
Anastrozole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000298	0.000709	CcSEcCtD
Anastrozole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.000709	CcSEcCtD
Anastrozole—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000298	0.000709	CcSEcCtD
Anastrozole—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000297	0.000707	CcSEcCtD
Anastrozole—Headache—Tretinoin—peripheral nervous system neoplasm	0.000296	0.000705	CcSEcCtD
Anastrozole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.000705	CcSEcCtD
Anastrozole—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000296	0.000705	CcSEcCtD
Anastrozole—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.000703	CcSEcCtD
Anastrozole—Constipation—Vincristine—peripheral nervous system neoplasm	0.000296	0.000703	CcSEcCtD
Anastrozole—Pain—Vincristine—peripheral nervous system neoplasm	0.000296	0.000703	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000703	CcSEcCtD
Anastrozole—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000295	0.000703	CcSEcCtD
Anastrozole—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000701	CcSEcCtD
Anastrozole—Rash—Melphalan—peripheral nervous system neoplasm	0.000295	0.000701	CcSEcCtD
Anastrozole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000294	0.0007	CcSEcCtD
Anastrozole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.000698	CcSEcCtD
Anastrozole—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000292	0.000695	CcSEcCtD
Anastrozole—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000291	0.000693	CcSEcCtD
Anastrozole—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000289	0.000687	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000684	CcSEcCtD
Anastrozole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.000678	CcSEcCtD
Anastrozole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.000678	CcSEcCtD
Anastrozole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.000675	CcSEcCtD
Anastrozole—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.000675	CcSEcCtD
Anastrozole—Nausea—Topotecan—peripheral nervous system neoplasm	0.000283	0.000674	CcSEcCtD
Anastrozole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000283	0.000672	CcSEcCtD
Anastrozole—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000282	0.000672	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00067	CcSEcCtD
Anastrozole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.000669	CcSEcCtD
Anastrozole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000281	0.000669	CcSEcCtD
Anastrozole—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00028	0.000666	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000666	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000663	CcSEcCtD
Anastrozole—Infection—Etoposide—peripheral nervous system neoplasm	0.000278	0.000662	CcSEcCtD
Anastrozole—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000278	0.00066	CcSEcCtD
Anastrozole—Nausea—Melphalan—peripheral nervous system neoplasm	0.000277	0.00066	CcSEcCtD
Anastrozole—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000657	CcSEcCtD
Anastrozole—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000657	CcSEcCtD
Anastrozole—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000274	0.000653	CcSEcCtD
Anastrozole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000273	0.00065	CcSEcCtD
Anastrozole—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000273	0.00065	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000649	CcSEcCtD
Anastrozole—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000272	0.000648	CcSEcCtD
Anastrozole—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000271	0.000644	CcSEcCtD
Anastrozole—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00064	CcSEcCtD
Anastrozole—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000267	0.000635	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000633	CcSEcCtD
Anastrozole—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000632	CcSEcCtD
Anastrozole—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000632	CcSEcCtD
Anastrozole—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000265	0.00063	CcSEcCtD
Anastrozole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.000629	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000264	0.000628	CcSEcCtD
Anastrozole—Pain—Cisplatin—peripheral nervous system neoplasm	0.000261	0.000622	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00062	CcSEcCtD
Anastrozole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.000612	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000608	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000608	CcSEcCtD
Anastrozole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000255	0.000606	CcSEcCtD
Anastrozole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.000604	CcSEcCtD
Anastrozole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000252	0.000599	CcSEcCtD
Anastrozole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000251	0.000598	CcSEcCtD
Anastrozole—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000598	CcSEcCtD
Anastrozole—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000594	CcSEcCtD
Anastrozole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00025	0.000594	CcSEcCtD
Anastrozole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000249	0.000592	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000592	CcSEcCtD
Anastrozole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000248	0.00059	CcSEcCtD
Anastrozole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000246	0.000585	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000584	CcSEcCtD
Anastrozole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000584	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00058	CcSEcCtD
Anastrozole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000244	0.00058	CcSEcCtD
Anastrozole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000243	0.000579	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000242	0.000575	CcSEcCtD
Anastrozole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000242	0.000575	CcSEcCtD
Anastrozole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000241	0.000574	CcSEcCtD
Anastrozole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000574	CcSEcCtD
Anastrozole—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000571	CcSEcCtD
Anastrozole—Constipation—Etoposide—peripheral nervous system neoplasm	0.000239	0.00057	CcSEcCtD
Anastrozole—Pain—Etoposide—peripheral nervous system neoplasm	0.000239	0.00057	CcSEcCtD
Anastrozole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000569	CcSEcCtD
Anastrozole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.000564	CcSEcCtD
Anastrozole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000236	0.000563	CcSEcCtD
Anastrozole—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000561	CcSEcCtD
Anastrozole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000554	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000553	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00055	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000549	CcSEcCtD
Anastrozole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000231	0.000549	CcSEcCtD
Anastrozole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.000547	CcSEcCtD
Anastrozole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000229	0.000545	CcSEcCtD
Anastrozole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000229	0.000544	CcSEcCtD
Anastrozole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.000543	CcSEcCtD
Anastrozole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.000538	CcSEcCtD
Anastrozole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.000538	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000537	CcSEcCtD
Anastrozole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000225	0.000536	CcSEcCtD
Anastrozole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.000535	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000531	CcSEcCtD
Anastrozole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000222	0.000529	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000528	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000528	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000527	CcSEcCtD
Anastrozole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000221	0.000527	CcSEcCtD
Anastrozole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000221	0.000527	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000527	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000526	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000526	CcSEcCtD
Anastrozole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00022	0.000523	CcSEcCtD
Anastrozole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000219	0.000522	CcSEcCtD
Anastrozole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000522	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000519	CcSEcCtD
Anastrozole—Rash—Vincristine—peripheral nervous system neoplasm	0.000218	0.000519	CcSEcCtD
Anastrozole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000218	0.000518	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000518	CcSEcCtD
Anastrozole—Headache—Vincristine—peripheral nervous system neoplasm	0.000217	0.000515	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000512	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000508	CcSEcCtD
Anastrozole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.000507	CcSEcCtD
Anastrozole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000498	CcSEcCtD
Anastrozole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000497	CcSEcCtD
Anastrozole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000206	0.000491	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000489	CcSEcCtD
Anastrozole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000205	0.000488	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000488	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000486	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000486	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000483	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000479	CcSEcCtD
Anastrozole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000201	0.000478	CcSEcCtD
Anastrozole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000198	0.000471	CcSEcCtD
Anastrozole—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000464	CcSEcCtD
Anastrozole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000194	0.000462	CcSEcCtD
Anastrozole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00046	CcSEcCtD
Anastrozole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000193	0.000458	CcSEcCtD
Anastrozole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000192	0.000458	CcSEcCtD
Anastrozole—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000458	CcSEcCtD
Anastrozole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000192	0.000456	CcSEcCtD
Anastrozole—Tension—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000449	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000448	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000444	CcSEcCtD
Anastrozole—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000443	CcSEcCtD
Anastrozole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000185	0.000441	CcSEcCtD
Anastrozole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000432	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00043	CcSEcCtD
Anastrozole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000425	CcSEcCtD
Anastrozole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000178	0.000424	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000423	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000423	CcSEcCtD
Anastrozole—Rash—Etoposide—peripheral nervous system neoplasm	0.000177	0.00042	CcSEcCtD
Anastrozole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000176	0.00042	CcSEcCtD
Anastrozole—Headache—Etoposide—peripheral nervous system neoplasm	0.000175	0.000417	CcSEcCtD
Anastrozole—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000415	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000415	CcSEcCtD
Anastrozole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000413	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000411	CcSEcCtD
Anastrozole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00041	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00041	CcSEcCtD
Anastrozole—Cough—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000399	CcSEcCtD
Anastrozole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000166	0.000396	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000395	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000393	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000391	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00039	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00039	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00039	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000388	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000385	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000382	CcSEcCtD
Anastrozole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000381	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000379	CcSEcCtD
Anastrozole—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000377	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000373	CcSEcCtD
Anastrozole—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000373	CcSEcCtD
Anastrozole—Infection—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000371	CcSEcCtD
Anastrozole—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000369	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000366	CcSEcCtD
Anastrozole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000361	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00036	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00036	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00036	CcSEcCtD
Anastrozole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000359	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000356	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000356	CcSEcCtD
Anastrozole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000353	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000348	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000346	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000346	CcSEcCtD
Anastrozole—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000343	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00034	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000338	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000335	CcSEcCtD
Anastrozole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000334	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000333	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000332	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000329	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000329	CcSEcCtD
Anastrozole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000325	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000322	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000322	CcSEcCtD
Anastrozole—Pain—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000319	CcSEcCtD
Anastrozole—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000319	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000315	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000313	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00031	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000308	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000308	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000307	CcSEcCtD
Anastrozole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000305	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000304	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.0003	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000298	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000298	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000297	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000295	CcSEcCtD
Anastrozole—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000295	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000295	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000295	CcSEcCtD
Anastrozole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000285	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000283	CcSEcCtD
Anastrozole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000275	CcSEcCtD
Anastrozole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000274	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000273	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000273	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000268	CcSEcCtD
Anastrozole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000264	CcSEcCtD
Anastrozole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000256	CcSEcCtD
Anastrozole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000255	CcSEcCtD
Anastrozole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000248	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000247	CcSEcCtD
Anastrozole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000244	CcSEcCtD
Anastrozole—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.000237	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000236	CcSEcCtD
Anastrozole—Rash—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000235	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000235	CcSEcCtD
Anastrozole—Headache—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000234	CcSEcCtD
Anastrozole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.000228	CcSEcCtD
Anastrozole—Nausea—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000222	CcSEcCtD
Anastrozole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.00022	CcSEcCtD
Anastrozole—Rash—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000218	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000218	CcSEcCtD
Anastrozole—Headache—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000216	CcSEcCtD
Anastrozole—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000205	CcSEcCtD
